As healthcare becomes more entrenched in the digital revolution, the need for an approved set of protocols for care delivery — clinical pathways — is becoming increasingly critical. Clinical pathways, ...

Structural and informational barriers drive nonrepresentative trial cohorts; aligning enrollment with catchment demographics and collaborating across centers improves generalizability and equity.

The free virtual series extends Clinical Pathways Congress with timely insights into evidence-based pathways, value assessment, and access. By extending Clinical Pathways Congress throughout the year, ...

Dynamic clinical pathways are essential to keep pace with rapid advancements in oncology treatments and FDA approvals. Inclusive participation and effective communication are vital for pathway ...

Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? In the article that accompanies ...

EHS has achieved a milestone in healthcare digital transformation through the implementation of multiple clinical pathways that are embedded within the Oracle Health Foundation Electronic Health ...

In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, ...

The US Food and Drug Administration (FDA) has submitted its budget proposal to Congress, outlining its spending priorities for fiscal year 2027. The budget request totals $7.2 billion, including $3.3 ...

Conducting first-in-human clinical trials in the United States is often associated with significant cost, complexity and delay. There is a ...